Judge Profile

John F. Horvath

49 IP cases indexed. Covers patent matters.

Cases Presided Over

49 cases indexed | Page 1 of 2

patent terminated or settled

Apple Inc. v.NL Giken Inc.

· IPR2024-01277

Apple and NL Giken settled their IPR dispute over U.S. Patent 9,948,968 before the Board instituted a trial. The settlement agreement was deemed confidential and the proceeding was terminated.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01253

Apple’s IPR against Omni MedSci’s ‘533 patent resulted in all challenged claims being found unpatentable. The Board held that the claims were obvious over prior‑art references Lisogurski, Carlson, and Mannheimer.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01254

Apple prevailed in an IPR against Omni MedSci, finding claims 7 and 10‑14 of the ’299 patent unpatentable for obviousness over Lisogurski, Carlson, Mannheimer, and Park references.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01250

Apple’s petition succeeded; the PTAB held all challenged claims of Omni MedSci’s wearable physiological measurement patent unpatentable as obvious over Lisogurski, Carlson, and Mannheimer references.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01251

Apple’s IPR against Omni MedSci’s wearable health‑monitoring patent resulted in the Board finding all challenged claims unpatentable as obvious over a combination of prior‑art references.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01251

Apple’s inter‑partes review of Omni MedSci’s ’533 patent resulted in the PTAB finding all challenged claims unpatentable for obviousness over Lisogurski, Carlson, and Mannheimer.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01252

Apple’s IPR against Omni MedSci’s wearable physiological measurement patent resulted in all challenged claims being held unpatentable. The Board found the claims obvious over Lisogurski, Carlson, and Mannheimer under §103(a).

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· IPR2025-01253

Apple’s IPR resulted in the Board finding all six challenged claims of Omni MedSci’s ’299 patent unpatentable as obvious over a combination of prior‑art references covering wearable optical sensing.

patent all challenged claims unpatentable

WHOOP, Inc. v.Omni MedSci, Inc.

· IPR2025-01584

The PTAB held that WHOOP’s challenge to Omni MedSci’s 9,651,533 patent failed; all asserted claims were found obvious over Lisogurski, Carlson, and Mannheimer under §103(a).

patent all challenged claims unpatentable

WHOOP, Inc. v.Omni MedSci, Inc.

· IPR2025-01583

The PTAB held that all challenged claims of the ’533 wearable physiological measurement patent were unpatentable as obvious over Lisogurski, Carlson, and Mannheimer references.

patent all challenged claims unpatentable

WHOOP, Inc. v.Omni MedSci, Inc.

· IPR2025-01585

The PTAB held that WHOOP’s challenge succeeded, finding all of the asserted claims of Omni MedSci’s ‘533 patent unpatentable as obvious over Lisogurski, Carlson, and Mannheimer prior art.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· PGR2025-00063

Apple’s IPR against Omni MedSci’s ‘299 patent was decided with all challenged claims (7, 10‑14) found unpatentable as obvious over Lisogurski, Carlson, Mannheimer, and Park references.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· PGR2025-00064

Apple’s IPR of Omni MedSci’s 9,651,533 patent was decided with all challenged claims found unpatentable under §103, based on obviousness over Lisogurski, Carlson, and Mannheimer prior art.

patent all challenged claims unpatentable

SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.

· PGR2025-00063

Apple succeeded in invalidating Omni MedSci's wearable physiological measurement patent, with the PTAB finding all challenged claims obvious over prior art.

patent instituted

VIVITRO LABS INC. v.BIOMEDICAL DEVICE CONSULTANTS & LABORATORIES OF COLORADO, LLC

· IPR2024-00320

VIVITRO LABS INC. successfully achieved institution at the PTAB for its IPR against Patent No. 9237935, challenging claims related to prosthetic heart valve testing systems. The Board found a reasonable likelihood of success over Dynatek regarding certain limitations, despite preliminary rejections on other grounds.

patent instituted

Microsoft Corporation et al. v.InterDigital Patent Holdings, Inc. et al.

· IPR2024-00537

The PTAB instituted an IPR challenge against InterDigital's patent 8737933, finding a reasonable likelihood of prevailing for Microsoft. The Board rejected the Patent Owner's attempt to secure discretionary denial, moving the case to the merits phase.

patent instituted

Microsoft Corporation et al. v.InterDigital Patent Holdings, Inc. et al.

· IPR2024-00538

Microsoft Corporation successfully challenged InterDigital Patent Holdings, Inc.'s patent claims in a PTAB decision. The Board found that the petitioner demonstrated a reasonable likelihood of prevailing on all asserted grounds regarding anticipation and obviousness. This institution decision keeps the dispute alive for further review.

patent instituted

MediaTek Inc. et al. v.MOSAID Technologies Inc.

· IPR2024-00598

MediaTek successfully petitioned to challenge MOSAID's '306 Patent, leading the PTAB to institute proceedings on 51 claims. The Board applied plain and ordinary meaning to key claim terms despite patent owner arguments, setting the stage for a full trial.

patent instituted

MediaTek Inc. et al. v.MOSAID Technologies Inc.

· IPR2024-00599

MediaTek successfully challenged MOSAID's patent (7224563) in the PTAB, leading to institution of the IPR. The Board found a reasonable likelihood of prevailing on multiple grounds of obviousness over prior art references like Tam and Huard.

patent instituted

MediaTek Inc. et al. v.MOSAID Technologies Inc.

· IPR2024-00600

MediaTek successfully secured institution at the PTAB against MOSAID Technologies regarding integrated circuit patents related to power management. The Board accepted Petitioner's showing of reasonable likelihood that claims are unpatentable over prior art references, including Takahashi and Mizuno.

patent denied

MediaTek Inc. et al. v.MOSAID Technologies Inc.:

· IPR2024-00718

The PTAB denied MediaTek's IPR challenge against MOSAID regarding power management technology. Despite a dissenting judge arguing for reasonable likelihood based on Nowka and Borkar, the Board found Petitioner failed to demonstrate sufficient motivation or intrinsic support for its obviousness theories.

patent instituted

MediaTek Inc. et al. v.MOSAID Technologies Inc.:

· IPR2024-00719

MediaTek Inc. successfully petitioned to institute an IPR against MOSAID Technologies Inc.'s patent, challenging all 64 claims based on obviousness (103). The Board found that MediaTek demonstrated a reasonable likelihood of prevailing by combining prior art references Nowka and Borkar in the field of integrated circuit power management.

patent denied

MediaTek Inc. et al. v.MOSAID Technologies Inc.

· IPR2024-00720

The PTAB denied MediaTek's IPR against MOSAID's patent 8253438. The Board found that the Petitioner failed to demonstrate a reasonable likelihood of showing obviousness over prior art references like Takahashi and Mizuno, particularly regarding the 'plurality of power islands' limitation.

patent denied

MediaTek Inc. et al. v.MOSAID Technologies Inc.

· IPR2024-00721

The PTAB denied MediaTek's IPR against MOSAID, finding that the Petitioner failed to demonstrate a reasonable likelihood of unpatentability over prior art references related to integrated circuit power management.

patent instituted

Sony Corporation v.Optimum Imaging Technologies LLC

· IPR2024-00923

Sony Corporation successfully navigated the PTAB process, leading to the institution of IPR on all 27 challenged claims related to digital camera aberration correction. The Board found a reasonable likelihood that Sony's technology is unpatentable over prior art disclosures from Watanabe and others.

patent instituted

Sony Corporation v.Optimum Imaging Technologies LLC

· IPR2024-00924

Sony Corporation successfully moved forward with its IPR challenge against Optimum Imaging Technologies LLC, as the PTAB declined to deny institution despite arguments regarding parallel district court litigation. The Board found sufficient merit in the petition, focusing on whether prior art (Watanabe) renders key digital imaging claims obvious under 35 U.S.C. § 103.

patent instituted

Sony Corporation v.Optimum Imaging Technologies LLC

· IPR2024-00925

Sony Corporation successfully secured institution in its IPR challenge against Optimum Imaging Technologies LLC regarding digital image processing claims. The Board found a reasonable likelihood of unpatentability over prior art, moving the case to the merits phase.

patent denied

Cambridge Mobile Telematics, Inc. v.Sfara, Inc.

· IPR2024-00952

The PTAB denied institution of IPR for Cambridge Mobile Telematics against Sfara, citing Petitioner's failure to provide a proper claim construction under 37 C.F.R. § 42.104(b)(3). Additionally, the Board found that key 'component' terms functioned as means-plus-function limitations lacking cognizable structure in the patent specification.

patent denied

Cambridge Mobile Telematics, Inc. v.Sfara, Inc.

· IPR2024-00966

The PTAB denied institution of IPR for Cambridge Mobile Telematics against Sfara, citing Petitioner's failure to properly construe means-plus-function claim terms under Rule 104(b)(3).

patent instituted

Sony Corporation v.Optimum Imaging Technologies LLC

· IPR2024-01046

Sony Corporation successfully secured institution for its IPR challenge against Optimum Imaging Technologies LLC's '266 patent. The Board found that Sony demonstrated a reasonable likelihood of showing unpatentability, allowing the case to proceed to trial on all 22 challenged claims.

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →